baber/WOPTO huggingface dataset:
Patent CA-2772686-A1 (CA)
Title: Assembly and indicator for a drug delivery device
Inventor: PLUMPTRE DAVID
IPC: A61M5/145
Filed: 2010-09-21
Abstract: An assembly for a drug delivery device (1), comprising a housing (2) having a proximal end and a distal end, a piston rod (8) and an indicator (13). The piston rod (8) is adapted to be displaced distally with respect to the housing (2) away from a proximal start position and towards a distal end position for delivering a drug (31). The indicator (13) is adapted for indicating at least two different operation conditions of the assembly, the indicator (13) being moveable with respect to the housing (2) from a first indication position for a first condition of the assembly into a second indication position for a second condition of the assembly. The piston rod (8) and the indicator (13) are configured to mechanically interact for converting movement of the piston rod (8) into movement of the indicator (13). A first detent (21) is provided which is configured to releasably secure the indicator (13) in the first indication position such that movement into the second indication position is allowed. A second detent (22) is provided which is configured to secure the indicator (13) in the second indication position such that movement into the first indication position is prevented.
Patent CA-2773103-A1 (CA)
Inventor: WIEHN HELMUT
IPC: E04B1/94
Filed: 2012-03-27
Abstract: Fire-resistant OSB (oriented strand board) material (1) consisting of a middle layer (3) and two outer layers (2), whereby the layers (2, 3) primarily consist of bonded wood flakes (4), characterised in that there are one or more fire-retardant agents in the middle layer (3) and one or both outer layers (2), and the nature and/or the concentrations of them in the middle layer (3) are different to the nature and/or the concentrations of them in one or both outer layers (3).
Patent CA-2773498-A1 (CA)
Inventor: ROOS WILLEM FREDERIK
IPC: B01J2/16
Filed: 2010-08-10
Abstract: The present invention relates to a process for the preparation of granules comprising the steps of: providing a granulation zone comprising particles, the particles being kept in motion; providing a first feed stream comprising a liquid composition into the granulation zone, the liquid composition being applied onto or over the moving particles in the granulation zone; withdrawing a product stream comprising granules from the granulation zone, the granules being the result of layered growth of the moving particles in the granulation zone; wherein a second feed stream comprising granulation nuclei is fed into the granulation zone, wherein the granulation nuclei have a particle size distribution characterized by a standard deviation of the particle size that is less than 15% of the mean particle size, and wherein the second feed stream comprises between 0.05 wt% and 50 wt% of the product stream.
Patent CA-2773869-A1 (CA)
Title: Vehicle emergency egress system
Inventor: SHELLENBERGER RUSSELL W
IPC: B60J1/00
Filed: 2010-08-09
Abstract: A vehicle emergency egress system. In one embodiment, an emergency egress system for providing an opening for egress from a vehicle includes a frame (2) configured to be directly attached to the vehicle, the frame having a cavity (3,4) formed therein and defined on a first side by a front surface (13a) facing an exterior of the vehicle, the front surface having an opening (3a, 4a) formed therethrough; a panel (5) removably received in the cavity for covering the opening (3a, 4a), the front surface retaining the panel in a first direction; and at least a bracket (8,9) removably attached to the frame (2) on the exterior of the vehicle and retaining the panel (5) in a second direction opposite the first direction, wherein the bracket is detachable from the frame by an occupant inside the vehicle for removal of the panel to the exterior of the vehicle in the second direction.
Patent CA-2777126-A1 (CA)
Title: Biomedical electrode
Inventor: BESIO WALTER
IPC: A61B5/296
Filed: 2010-10-27
Abstract: A biomedical electrode is disclosed that includes at least first and second electrical nodes for connection to medical equipment. The biomedical electrode includes a first electrical node including a disc of conductive material having a diameter d1 and a second electrical node including a ring of conductive material. The ring is concentric with the disc and- has a diameter d2 that is larger than d1 and having a ring thickness t2 such that (4 = d1 / t2 = 6). It is further disclosed a biomedical electrode providing at least first, second, third and fourth electrical nodes for connection to medical equipment, said biomedical electrode comprising said first electrical node including a disc of conductive material having a diameter d1; said second electrical node including a first ring of conductive material, said first ring being concentric with the disc and having a radius a that is larger than d1/2; and said third electrical node including a second ring of conductive material, said second ring also being concentric with the disc and having a radius ß that is larger than d2/2; said fourth electrical node including a third ring of conductive material, said third ring also being concentric with the disc and having a radius of thirty millimeters that is larger than d3/2, such that (3 a ß)2 is less than about 0.225 cm4.
Patent CA-2777366-A1 (CA)
Inventor: FOLGER MARTIN A
IPC: A61J1/00
Filed: 2010-10-11
Abstract: A plastic container containing a pharmaceutical composition comprising benzoic acid or a derivative or a pharmaceutically acceptable salt thereof and a COX-inhibitor of the oxi- cam-type or a pharmaceutical acceptable salt thereof, wherein the container material se¬ lected from one or more members of the group consisting of a homopolymer of polypro¬ pylene (PP), a copolymer of polypropylene (PP), a homopolymer of polyethylene terephthalate (PET) and a copolymer of polyethylene terephthalate (PET), and optionally one or more non-polymeric components.
Patent CA-2778675-A1 (CA)
Title: Combination therapy for treating cancer and diagnostic assays for use therein
Inventor: SHAH OMAR JAMEEL
IPC: A61K31/506
Filed: 2010-12-01
Abstract: The present disclosure relates to a combination of therapeutic agents for use in treating a patient suffering from cancer, wherein said combination comprises at least one polyploidy inducing agent and at least one Bel - 2 family protein inhibitor. In addition, the present disclosure also relates to diagnostic assays useful in classification of patients for treatment with one or more therapeutic agents.
Patent CA-2778955-A1 (CA)
Inventor: HATAMI-HANZA HAMID
IPC: G06Q30/02
Filed: 2012-05-30
Abstract: The present invention provides methods and systems of executing the method/s of financing and/or marketing a venture or product while rewarding the revenue contributing clients of an enterprise based on the stage or the state that they make a revenue contribution to the enterprise. One of the objectives of this invention is to entitle the clients with a reward such as a stock that is appreciable through the growth and success of the enterprise. Such reward "program" is a function of the enterprise market value and the amount of client's revenue contribution at the time of the "revenue contribution event".
Patent CA-2780576-A1 (CA)
Title: Optical backplane rack assembly with external optical connectors
Inventor: ROLSTON DAVID R
IPC: H04B10/02
Filed: 2010-11-01
Abstract: There is described a line card rack assembly for line cards, and an optical backplane and optical fiber guide for installation to a frame adapted to receive line cards of which at least one has an optical connector at a front portion thereof. The rack assembly comprises a frame having a front opening, for receiving the line cards and providing access to a front end of the line cards, and a back opening opposite the front opening; an optical backplane at least partially covering the back opening, the optical backplane comprising connections for connecting the line cards upon insertion in the frame; and optical fiber cable having two ends, a first one of the two ends being for coupling to the optical backplane, and a second one of the two ends for coupling to the optical connector of the at least one of the line cards.
Patent CA-2782762-A1 (CA)
Title: Garment having support
Inventor: WALDMAN MARK
IPC: A41D1/06
Filed: 2010-12-02
Abstract: A garment including a body of fabric having a waistband and at least two seams that extend from the waistband and a support structure that is connected to the at least two seams and the waistband is provided. The support structure further includes a pocket and a tape connected to the pocket that prevents elongation of the support structure between said at least two seams during the wearable life of the body of fabric.
Patent CA-2784355-A1 (CA)
Inventor: GUTIERREZ CHRISTINA
IPC: C12P19/44
Filed: 2010-12-17
Abstract: The present disclosure is directed, in a first aspect, to the use of inverting beta-xylosidase enzymes to reduce byproduct formation and increase the yield of fermentation products, as well as, in a second aspect, to the use of retaining beta-xylosidase enzymes to improve production of alkyl-beta-xylopyranoside compounds, in a simultaneous saccharification and fermentation reactions.
Patent CA-2785735-A1 (CA)
Title: Apparatus and method for pumping a fluid and an additive from a downhole location into a formation or to another location
Inventor: LANNOM ROBERT W
IPC: E21B43/12
Filed: 2010-12-29
Abstract: An apparatus and methods for pumping a fluid mixture from a wellbore location to a selected location is disclosed. The apparatus, in one embodiment, includes a container configured to be placed in the wellbore, wherein the container is configured to mix therein a fluid received from a first source and an additive received from a second source, and a pump unit coupled to the container and configured to pump the mixed fluid from the container to the selected location. The method in one embodiment includes: supplying a fluid from a first source to a container placed in a wellbore; supplying an additive from a second source to the container; allowing the fluid and the additive to mix in the container to form a mixed fluid; and pumping the mixed fluid from the container to the selected location.
Patent CA-2786120-A1 (CA)
Inventor: SATO HIROKI
IPC: C01B32/50
Filed: 2012-08-15
Abstract: A carbon dioxide recovery system is provided, in which, a filling rate of the carbon dioxide sorbent in the container indicated by f [%] is positive and larger than or equal to the value obtained by the following expression of 100 × (p/(RT)) × (x-C)/(a × (100 + x/r - 100 × x/(rC) - x) + (p/(RT)) × (x-C)), with respect to the effective molar quantity of the captured carbon dioxide per 1 L of the carbon dioxide sorbent (= a) of the carbon dioxide sorbent to be used, wherein a demanded concentration of recovered carbon dioxide is indicated by x [%], and an amount of the captured gases other than carbon dioxide is indicated by r, and a concentration of dried carbon dioxide in a carbon dioxide-containing gas is indicated by C [%], and a total pressure of the carbon dioxide sorbent occurring when carbon dioxide is captured is indicated by p [Pa].
Patent CA-2792411-A1 (CA)
Title: Method for proliferating cardiomyocytes using micro-rna
Inventor: KAWASHIMA KAYOKO
IPC: A61K35/34
Filed: 2011-03-11
Abstract: Disclosed are: a method for proliferating cardiomyocytes, wherein a miRNA that promotes the proliferation of cardiomyocytes is used; a vector for the treatment of heart diseases; and a pharmaceutical composition or the like for the treatment of heart diseases. Specifically disclosed are: a method for proliferating cardiomyocytes, which uses a miRNA that has a cardiomyocyte proliferation promoting action; a vector for the treatment of heart diseases, which comprises the miRNA; and a pharmaceutical composition or the like for the treatment of heart diseases, which contains the vector. The miRNA is preferably one selected from the group consisting of miR-148a, miR-148b, miR-152 and miR-373 that are mature miRNAs, precursors of the aforementioned miRNAs, and mutants and analogues of the miRNAs and the precursors.
Patent CA-2793027-A1 (CA)
Title: Comparative genomic hybridization array method for preimplantation genetic screening
Inventor: CRAIG ANDREW
IPC: G16B20/10
Filed: 2011-02-28
Abstract: A method for determining the presence of a copy number imbalance in genomic DNA of a test sample is provided. The method can separately measure hybridization of a single test sample to a first hybridization array and hybridization of a plurality of reference samples to a plurality of other, respective test arrays. A determination of copy number can be based on the best fit reference array, relative to the test array. The best fit can be determined based on the closest or most similar signal-to-noise ratio of the measured signals.
Patent CA-2793155-A1 (CA)
Title: Powder supply system and method for colour change in a powder supply system
Inventor: KLEINEIDAM ANDREAS
IPC: B05B5/16
Filed: 2011-04-11
Abstract: The invention relates to a Powder supply system for supplying powder to a powder spray device comprising a powder supply hopper; a powder fluidizing device for fluidizing powder positioned in the powder supply hopper; a powder pump for conveying powder from the powder supply hopper to the spray device. According to the invention the powder supply hopper is pivotally mounted to a support structure. The invention further relates to a method for colour change in a powder supply system.
Patent CA-2794480-A1 (CA)
Inventor: TRONCOSO KIRSTEN JOSE MIGUEL
IPC: A61P31/00
Filed: 2011-03-28
Abstract: The present invention relates to a propyl-methyl-phenol compound, in particular thymol and/or carvacrol or composition comprising a propyl-methyl-phenol compound for use in the treatment and/or prophylaxis of Salmonid rickettsial septicemia (SRS) and/or diseases caused by Piscirickettsia salmonis, and/or for the use in killing, combating or controlling Piscirickettsia salmonis, and for use in the treatment and/or prophylaxis of Infectious salmon anemia (ISA) and/or diseases caused by Infectious salmon anemia virus, and/or for the use in killing, combating or controlling Infectious salmon anemia virus.
Patent CA-2794825-A1 (CA)
Title: Procede d'adaptation de debit d'air de turbomachine a compresseur centrifuge et diffuseur de mise en oeuvre
Inventor: BISCAY PIERRE
IPC: F04D29/44
Filed: 2011-04-13
Abstract: L'invention vise à maintenir le rendement et le taux d'un compresseur de turbomachine pour diminuer sensiblement la consommation spécifique Cs, tout en garantissant une marge au pompage suffisante à charge partielle. Pour ce faire, il est proposé un procédé optimisé d'adaptation du flux d'air à une demande variable de débit ou de puissance mécanique ou électrique dans un compresseur centrifuge de turbomachines. Le procédé prévoit une diffusion du flux d'air (F) à travers un premier aubage annulaire (G1) de pales à calage variable (24) bordé radialement d'un deuxième aubage annulaire (G2) de même nombre de pales à calage fixe (28) d'extension équivalente, orientant la diffusion en extension radiale par couplage des pales (24, 28) des deux aubages. Selon ce procédé, chaque pale (24) du premier aubage (G1) est entraînée en rotation propre hors d'axe.
Patent CA-2797437-A1 (CA)
Title: Peptides and their use as antimicrobial agents
Inventor: O'NEIL DEBORAH
IPC: A61K38/08
Filed: 2011-03-30
Abstract: The present invention relates to peptides and their use in the treatment of microbial infections, in particular bacterial infections. In particular, the invention relates to peptides wherein at least 75% of the amino acids of the peptide are arginine and phenylalanine amino acids, at least 50% of the amino acids being arginine amino acids and at least 15% of the amino acids being phenylalanine amino acids.
Patent CA-2798181-A1 (CA)
Title: Combination therapy and method for assessing resistance to treatment
Inventor: BOYLAN JOHN FREDERICK
IPC: G01N33/574
Filed: 2011-05-17
Abstract: The present invention relates to a method for determining a subject's resistance to treatment with 2,2-dimethyl-N-((S)-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-N'-(2,2,3,3,3-pentafluoro- propyl)-malonamide by measuring the levels a biomarker or biomarkers present in a biological sample obtained from the subject, the biomarker being IL6 and/or IL8. The present invention also relates to a combination therapy for a patient suffering from a proliferative disorder comprising administering to the patient 2,2-Dimethyl-N-((S)-6-oxo-6,7-dihydro-5H- dibenzo[b,d]azepin-7-yl)-N'-(2,2,3,3,3-pentafluoro-propyl)-malonamide and an anti-IL6 and/or an anti-IL8 agent.
Patent CA-2801059-A1 (CA)
Inventor: COOK FRANCIS
IPC: H04N7/16
Filed: 2011-05-25
Abstract: L'invention se rapporte à un procédé permettant de créer un fichier de métadonnées pour un guide électronique de programme (EPG), qui consiste à recevoir des métadonnées de programme et à les transformer en fichier au moyen de la norme de codage du Fast Infoset (FI). Ledit procédé est appliqué à un serveur de recherche de métadonnées (MSS) destiné à fournir des services en rapport avec un guide électronique de programme (EPG), le MSS (1) utilisé étant en communication avec une pluralité de boîtiers décodeurs (STB) (3) et un ou plusieurs fournisseurs de métadonnées (11, 12) qui fournissent des métadonnées de programme. Le MSS (1) comprend un codeur (15) conçu pour coder les métadonnées de programme reçues en provenance du ou des fournisseurs de métadonnées (11, 12) afin d'obtenir un fichier d'EPG à diffuser selon la norme du Fast Infoset (FI).
Patent CA-2801318-A1 (CA)
Inventor: BRYANTSEV ALEXANDER MIKHAILOVICH
IPC: H01F29/14
Filed: 2011-02-18
Abstract: The invention relates to electrical engineering and can be used in reactors controlled by magnetization which are installed, for example, in an electrical circuit for reactive power compensation, for voltage stabilization, for parallel operation with capacitor batteries, for increasing the transmission capacity etc. The technical result consists in decreasing the consumption of electrical steel, and reducing the costs and labour intensiveness in manufacture. The reactor comprises a magnetic system consisting of vertical bars, horizontal yokes, magnetic shunts as well as windings arranged on each bar and windings surrounding two neighbouring bars, as well as a controllable DC voltage source. The three-dimensional magnetic system consists of two three-phase magnetic circuits arranged in parallel planes. Additional portions of the yokes in the form of ferromagnetic inserts which connect the magnetic circuits to one another along the horizontal yokes are installed between the magnetic circuits. The steel section of the ferromagnetic inserts SBCT. and of the bars SCT. are associated by the ratio 0.8<(SBCT.:SCT.)<1.2.
Patent CA-2802122-A1 (CA)
Inventor: ROTHACHER URS MARTIN
IPC: H04N7/18
Filed: 2010-06-10
Abstract: The present idea refers to a method and a control unit for controlling a display (19) of a proximity warning system. Vehicles and other objects (4a, 4b, 4c, 5, 6, 7, 8), for example, in a surface mine (1), are equipped with cameras (12) for providing images of different scenes. A control unit (13) of such object (4a, 4b, 4c, 5, 6, 7, 8) receives a signal representing positional information of such object from a radio based positioning receiver (11). Dependent on the positional information a subset of at least one camera (12) is selected, and a control signal is provided for the display (19) to display images provided by the selected subset of one or more cameras (12).By such method, the most relevant scene in terms of collision avoidance can be displayed to the operator.
Patent CA-2802710-A1 (CA)
Inventor: WHITE JOSEPH F
IPC: B60C29/06
Filed: 2011-06-16
Abstract: A cap for a valve stem includes a housing extending along an axis from a first end to a second end. A bore extends along the axis from the first end toward the second end and a cup-shaped wall extends circumferentially about the bore for receiving the valve stem. A threaded surface is disposed in the bore for threadedly engaging the valve stem. A flange extends from the first end transversely to the axis and circumferentially around the bore for abutting the rim of the wheel to stabilize the housing relative to the rim of the wheel. Ribs are radially spaced about the housing and extend outwardly from the wall of the housing to the flange reinforcing the housing relative to the flange.
Patent CA-2802721-A1 (CA)
Title: Novel agonists of toll-like receptor 3 and methods of their use
Inventor: KANDIMALLA EKAMBAR
IPC: C07H21/02
Filed: 2011-06-24
Abstract: TLR3 agonist compounds, compositions and methods are provided for stimulating the activity of TLR3. The compositions comprise oligonucleotide-based compounds that bind to and activate TLR3. The compositions may also comprise oligonucleotide-based compounds that bind to and activate TLR3 in combination with other therapeutic and/or prophylactic compounds and/or compositions. Methods of using these compounds and compositions for stimulation of TLR3 activity and for prevention or treatment of diseases wherein modulation of TLR3 activity would be beneficial are provided.
Patent CA-2803168-A1 (CA)
Title: Space-saving high-density modular data center and an energy-efficient cooling system
Inventor: COSTAKIS JOHN
IPC: H05K7/20
Filed: 2011-06-23
Abstract: A space-saving, high-density modular data pod system and an energy-efficient cooling system are disclosed. The modular data pod system includes a central free- cooling system and a plurality of modular data pods, each of which includes a heat exchange assembly coupled to the central free-cooling system, and a distributed mechanical cooling system coupled to the heat exchange assembly. The modular data pods include a data enclosure having at least five walls arranged in the shape of a polygon, a plurality of computer racks arranged in a circular or U-shaped pattern, and a cover to create hot and cold aisles, and an air circulator configured to continuously circulate air between the hot and cold aisles. Each modular data pod also includes an auxiliary enclosure containing a shared fluid and electrical circuit section that is configured to connect to adjacent shared fluid and electrical circuit sections to form a shared fluid and electrical circuit that connects to the central free-cooling system. The auxiliary enclosure contains at least a portion of the distributed mechanical cooling system, which is configured to trim the cooling performed by the central free-cooling system.
Patent CA-2805684-A1 (CA)
Inventor: PETERSEN HANS
IPC: C07D307/87
Filed: 2011-07-12
Abstract: The present invention is concerned with a process in connection with the purification of a pharmaceutically acceptable salt of escitalopram or citalopram.
Patent CA-2806565-A1 (CA)
Inventor: REMENAR JULIUS F
IPC: C07D231/24
Filed: 2011-07-29
Abstract: Hydrated celecoxib sodium salt forms and processes to prepare hydrated celecoxib sodium salt forms are disclosed. The celecoxib sodium salt forms are particularly useful and suitable for pharmaceutical applications.
Patent CA-2807358-A1 (CA)
Inventor: MURPHY RICHARD
IPC: A63H33/12
Filed: 2011-06-10
Abstract: A connector element for a space structure of a type utilizing a plurality of struts. The connector element includes first and second subparts, at least one strut receiving element having a strut receiving socket emanating from each of the subparts, the subparts being rotatable with respect to one another along a common axis.
Patent CA-2811137-A1 (CA)
Inventor: FUERST MICHAEL
IPC: C09J7/02
Filed: 2011-08-31
Abstract: The present invention relates to a process for producing a polymeric film which is furnished on one side with a cured polysiloxane coating and has an overall thickness = 45 µm by furnishing both sides of a collapsed, preferably tubular film with a cured polysiloxane coating, comprising steps (a) to (e), to a film obtainable by this process and to the use of such a film as a release film and/or protective film.